summary
Introduced
02/06/2025
02/06/2025
In Committee
02/06/2025
02/06/2025
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Creates the Wholesale Prescription Drug Importation Program Act. Requires the Department of Public Health to establish the Wholesale Prescription Drug Importation Program. Provides that the Department shall implement the program by: (1) contracting with one or more prescription drug wholesalers and Canadian suppliers to import prescription drugs and provide prescription drug cost savings to consumers in this State; (2) developing a registration process for health benefit plan issuers, health care providers, and pharmacies to obtain and dispense prescription drugs imported under the program; (3) developing a list of prescription drugs, including the prices of those drugs, that meet certain requirements set forth under the Act and publishing the list on the Department's website; (4) establishing an outreach and marketing plan to generate program awareness; (5) ensuring the program and the prescription drug wholesalers that contract with this State comply with certain federal tracking, tracing, verification, and identification requirements; and other matters. Sets forth eligibility criteria for prescription drugs that may be imported into the State under the program. Contains provisions concerning program expansion; program funding; audit procedures; annual reporting requirements; the adoption of rules to implement the Act; and federal waiver or authorization requirements. Effective July 1, 2025.
AI Summary
This bill creates the Wholesale Prescription Drug Importation Program, which allows the Illinois Department of Public Health to import prescription drugs from Canada to help reduce medication costs for state residents. The program will involve contracting with prescription drug wholesalers and Canadian suppliers to import drugs that meet specific safety and eligibility criteria, such as being FDA-approved, not violating patent laws, and offering consumer cost savings. The bill excludes certain drug types like controlled substances, biological products, and intravenous medications from the program. The Department will develop a registration process for health benefit plans, providers, and pharmacies, create a list of eligible drugs with their prices, establish an outreach plan, and ensure compliance with federal drug tracking requirements. The program will include audit procedures, annual reporting to the Governor and General Assembly about program performance and cost savings, and the potential to expand to other countries permitted by federal law. The Department may fund the program through legislative appropriations or by imposing fees on imported drugs. The bill is set to take effect on July 1, 2025, and allows for delays in implementation if federal waivers or authorizations are required.
Sponsors (4)
Last Action
Added as Co-Sponsor Sen. Mary Edly-Allen (on 03/20/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=1971&GAID=18&DocTypeID=SB&SessionID=114&GA=104 |
| BillText | https://www.ilga.gov/legislation/104/SB/10400SB1971.htm |
Loading...